Carmed Pharmaceuticals, a science-driven company specializing in standardized carvacrol-based formulations, is preparing to expand its U.S. distribution with an upcoming launch on Amazon.

The planned rollout marks an important step in increasing accessibility to Carmed’s formulations, enabling U.S. consumers to discover and purchase its products through a widely used digital marketplace.

Built on a foundation of structured research and formulation science, Carmed develops standardized botanical formulations designed to support immune resilience, cellular health, and overall physiological balance.

Advancing U.S. Availability Through Digital Channels

Carmed’s expansion onto Amazon reflects the company’s strategy of pairing scientific development with modern distribution platforms that improve product accessibility and consumer reach.

The company aims to meet growing demand for quality-controlled botanical formulations by making its products easier to access through familiar purchasing channels.

“Our focus is to deliver formulations that are consistent, standardized, and grounded in scientific methodology,” said Mustafa Can, Founder of Carmed Pharmaceuticals. “Expanding onto Amazon allows us to reach a broader audience while maintaining the same commitment to research and quality that defines our work.”

Product Portfolio Planned for Amazon

As part of its Amazon rollout, Carmed Pharmaceuticals plans to introduce several of its core formulations:

• Vacrol® Kids Spray - A carvacrol-based spray formulated to support upper respiratory wellness and microbial balance for children ages 4-11.

• S-Mix® - A synergy-driven formulation designed to support immune function and healthy cellular activity.

• Vacrol® Capsule - A standardized carvacrol formulation developed to support microbial balance and immune resilience.

• Vacrol-M® Capsule - A multi-component botanical formulation designed to support immune function and respiratory wellness.

• Omevaq-3® - A targeted formulation developed to support cellular energy metabolism and cognitive wellness.

Vacrol® Kids Spray and S-Mix® are gluten-free, non-GMO, sugar-free, preservative-free, and halal-certified.

According to the company, all formulations are developed using standardized processes designed to ensure consistency, reproducibility, and quality control across production.

Research-Driven Development Model

Carmed’s formulation approach is supported by ongoing collaboration with academic institutions, laboratories, and medical researchers focused on bioactive compounds and formulation science.

In January 2026, a study published in the peer-reviewed journal Plants examined Vacrol® and S-Mix® in preclinical laboratory and in ovo models, contributing to the broader scientific investigation of carvacrol-based formulations and multicomponent botanical interactions.

The company emphasizes that this research reflects scientific investigation into formulation science and is not presented as evidence that its consumer products diagnose, treat, cure, or prevent any disease.

Scaling Distribution in the U.S. Market

Carmed’s U.S. strategy focuses on expanding availability while maintaining alignment with regulatory standards and long-term scientific positioning.

“The upcoming Amazon launch represents an important step in increasing awareness and accessibility for Carmed’s formulations in the United States,” said Ceren Can, Global Brand Director of Carmed Pharmaceuticals. “We are focused on building a strong foundation in the U.S. market through consistent product quality and a research-driven approach.”

The company expects to announce product availability and listing details on Amazon in the coming weeks.

About Carmed Pharmaceuticals

Carmed Pharmaceuticals is a research-driven company specializing in standardized, mechanism-based botanical formulations rooted in Anatolia’s rich botanical heritage. Integrating traditional plant knowledge with modern pharmaceutical technology, Carmed focuses on analytical validation, quality control, and reproducible formulation design.

Officially established in 2019 following years of focused research and development, the company operates with nearly 15 years of industry experience. All products are manufactured in accordance with Good Manufacturing Practice (GMP) principles and relevant regulatory standards, emphasizing safe production, environmental awareness, and continuous quality improvement.

Carmed develops standardized formulations designed to support preventive wellness, immune resilience, and cellular health through science-informed, quality-controlled processes.

Visit Carmed Pharmaceuticals website and visit them on Instagram.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

Carmed Pharmaceuticals, a science-driven company specializing in standardized carvacrol-based formulations, announced plans to expand its U.S. presence with an upcoming launch on Amazon.

The expansion builds on Carmed’s entry into the United States market and represents the next step in making its research-driven botanical formulations more accessible to U.S. consumers through one of the world’s largest online retail platforms.

Carmed’s approach integrates traditional botanical knowledge with modern pharmaceutical methodology to develop standardized formulations designed to support immune resilience, cellular health, and overall physiological balance.

Expanding Access Through Amazon

The planned Amazon launch is designed to provide broader access to Carmed’s formulations while supporting the company’s long-term strategy of combining scientific development with scalable distribution.

By leveraging Amazon’s platform, Carmed aims to reach a wider audience seeking standardized, quality-controlled botanical formulations grounded in research and formulation science.

“Amazon allows us to make our formulations more accessible while maintaining our focus on scientific integrity and standardization,” said Mustafa Can, Founder of Carmed Pharmaceuticals. “Our goal is to ensure that every product reflects the same level of research, consistency, and quality that defines our development process.”

The company’s U.S. rollout is focused on accessibility, consistency, and maintaining alignment with regulatory standards as it expands into new distribution channels.

Product Portfolio Coming to Amazon

As part of its Amazon launch, Carmed Pharmaceuticals plans to introduce several of its flagship formulations:

• Vacrol® Kids Spray - A carvacrol-based spray formulated to support upper respiratory wellness and microbial balance for children ages 4-11.

• S-Mix® - A synergy-driven formulation designed to support immune function and healthy cellular activity.

• Vacrol® Capsule - A standardized carvacrol formulation developed to support microbial balance and immune resilience.

• Vacrol-M® Capsule - A multi-component botanical formulation designed to support immune function and respiratory wellness.

• Omevaq-3® - A targeted formulation developed to support cellular energy metabolism and cognitive wellness.

Vacrol® Kids Spray and S-Mix® are gluten-free, non-GMO, sugar-free, preservative-free, and halal-certified.

According to the company, Carmed’s formulations are developed using standardized processes designed to ensure consistency, reproducibility, and quality control across product batches.

Scientific Foundation and Ongoing Research

Carmed’s development model is supported by ongoing research and collaboration with academic institutions, laboratories, and medical researchers focused on formulation science and bioactive compound evaluation.

In January 2026, a study published in the peer-reviewed journal Plants examined Vacrol® and S-Mix® in preclinical laboratory and in ovo models as part of broader scientific investigation into carvacrol-based formulations and multicomponent botanical interactions.

The company emphasizes that such research reflects scientific investigation into botanical bioactivity and formulation design and is not presented as evidence that its consumer products diagnose, treat, cure, or prevent any disease.

U.S. Market Expansion

Carmed states that its U.S. strategy is centered on building long-term credibility through scientific rigor, regulatory alignment, and consistent product quality as it expands distribution.

“The Amazon launch is an important step in making Carmed’s formulations available to a broader audience in the United States,” said Ceren Can, Global Brand Director of Carmed Pharmaceuticals. “We are focused on delivering consistent, high-quality products while continuing to build awareness around our research-driven approach to formulation development.”

The Amazon launch represents a key milestone in that strategy, enabling broader consumer access while supporting continued investment in research and formulation development.

Availability timelines and product listings on Amazon will be announced in the coming weeks.

About Carmed Pharmaceuticals

Carmed Pharmaceuticals is a research-driven company specializing in standardized, mechanism-based botanical formulations rooted in Anatolia’s rich botanical heritage. Integrating traditional plant knowledge with modern pharmaceutical technology, Carmed focuses on analytical validation, quality control, and reproducible formulation design.

Officially established in 2019 following years of focused research and development, the company operates with nearly 15 years of industry experience. All products are manufactured in accordance with Good Manufacturing Practice (GMP) principles and relevant regulatory standards, emphasizing safe production, environmental awareness, and continuous quality improvement.

Carmed develops standardized formulations designed to support preventive wellness, immune resilience, and cellular health through science-informed, quality-controlled processes.

Visit Carmed Pharmaceuticals website and visit them on Instagram.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

Carmed Pharmaceuticals, a science-driven company specializing in standardized carvacrol-based formulations, is expanding into the United States market under the leadership of its founder, Mustafa Can.

The U.S. expansion follows years of research and formulation development led by Can, who established Carmed Pharmaceuticals in 2019 after several years of prior scientific exploration focused on standardized botanical bioactives and mechanism-based product design.

Carmed’s approach integrates traditional botanical knowledge with modern pharmaceutical methodology to create formulations designed to support immune resilience, cellular health, and overall physiological balance.

Founder Vision Behind Carmed Pharmaceuticals

Mustafa Can founded Carmed Pharmaceuticals with the goal of developing scientifically structured botanical formulations built on measurable mechanisms of action and rigorous quality control rather than trend-driven supplement concepts.

Before founding Carmed Pharmaceuticals, Mustafa Can built his career in the maritime industry as a ship master, navigating commercial vessels rather than laboratories. But about a decade ago, a personal fascination with longevity and preventive wellness set him on an unexpected new course. Without formal scientific training, Can immersed himself in an intense period of self-directed study—reviewing thousands of scientific publications and exploring the chemistry of botanical compounds used in traditional medicine. Over time, that curiosity evolved into a focused investigation of standardized, research-driven formulations centered on carvacrol and related bioactive ingredients.

As Carmed grew, that independent research effort expanded into a broader scientific initiative. Today, the company operates with a core team of approximately 25 full-time professionals and collaborates with a broader network of physicians, researchers, laboratories, and medical institutions involved in formulation development and scientific evaluation of bioactive compounds. What began as a personal pursuit of understanding ultimately became the foundation of Carmed Pharmaceuticals and its science-focused approach to botanical formulation development.

“From the beginning, our objective was to approach botanical formulations with scientific discipline,” said Can. “We wanted to focus on standardization, reproducibility, and analytical validation so that formulations are developed with a clear and consistent scientific rationale.”

Can added that Carmed’s long-term strategy prioritizes continued research and product development, with significant resources reinvested into scientific investigation and formulation development.

Today, Carmed operates with a research-driven framework that includes in vitro analysis, mechanism-based evaluation, formulation standardization, and structured quality control processes. All Carmed products are manufactured in facilities operating in accordance with Good Manufacturing Practice (GMP) principles and relevant regulatory standards.

Product Portfolio Entering the U.S.

As part of its U.S. expansion, Carmed Pharmaceuticals plans to introduce several of its flagship formulations:

• Vacrol® Kids Spray – A carvacrol-based spray formulated to support upper respiratory wellness and microbial balance for children ages 4–11.

• S-Mix® – A synergy-driven formulation designed to support immune function and healthy cellular activity.

• Vacrol® Capsule – A standardized carvacrol formulation developed to support microbial balance and immune resilience.

• Vacrol-M® Capsule – A multi-component botanical formulation designed to support immune function and respiratory wellness.

• Omevaq-3® – A targeted formulation developed to support cellular energy metabolism and cognitive wellness.

Vacrol® Kids Spray and S-Mix® are gluten-free, non-GMO, sugar-free, preservative-free, and halal-certified.

According to Can, Carmed’s development strategy focuses on combining botanical bioactives in standardized formulations designed to interact across multiple biological pathways.

“Our formulations are built on what we describe as rational synergy,” Can said. “Rather than relying on isolated ingredients, we design standardized combinations selected to work together in a consistent and reproducible manner.”

Scientific Collaboration and Long-Term Positioning

Carmed’s research efforts are supported by collaborations with academic institutions, laboratories, and medical researchers involved in formulation science and bioactive compound evaluation. In January 2026, a study published in the peer-reviewed journal Plants examined Vacrol® and S-Mix® in preclinical laboratory and in ovo models as part of broader scientific investigation into carvacrol-based formulations and multicomponent botanical interactions.

The company emphasizes that such research reflects scientific investigation into botanical bioactivity and formulation design and is not presented as evidence that its consumer products diagnose, treat, cure, or prevent any disease.

As it enters the United States, Carmed states its strategy is focused on regulatory alignment, scientific credibility, and long-term positioning within the preventive wellness sector.

Distribution timelines and retail availability for the United States will be announced in the coming months.

About Carmed Pharmaceuticals

Carmed Pharmaceuticals is a research-driven company specializing in standardized, mechanism-based botanical formulations rooted in Anatolia’s rich botanical heritage. Integrating traditional plant knowledge with modern pharmaceutical technology, Carmed focuses on analytical validation, quality control, and reproducible formulation design.

Officially established in 2019 following years of focused research and development, the company operates with nearly 15 years of industry experience. All products are manufactured in accordance with Good Manufacturing Practice (GMP) principles and relevant regulatory standards, emphasizing safe production, environmental awareness, and continuous quality improvement.

Carmed develops standardized formulations designed to support preventive wellness, immune resilience, and cellular health through science-informed, quality-controlled processes.

Visit Carmed Pharmaceuticals website and visit them on Instagram.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

Carmed Pharmaceuticals, a science-driven company specializing in standardized carvacrol-based formulations, has announced its expansion into the United States market.

The U.S. expansion is being formally announced in alignment with International Women’s Day on March 8, highlighting the company’s female leadership and its commitment to science-driven development within the preventive health sector.

Founded on a structured research pathway rather than short-term wellness trends, Carmed integrates traditional botanical knowledge with modern pharmaceutical technology to develop quality-controlled formulations designed to support immune resilience, cellular health, and overall physiological balance.

Officially established in 2019 following several years of focused research and development, the company brings nearly 15 years of industry experience to its U.S. expansion strategy.

Research-Driven Foundation

Carmed Pharmaceuticals was built around a strategic R&D model centered on formulation standardization, analytical validation, and reproducible development processes.

“Our foundation is not built on trends,” said Mustafa Can, Founder and CEO of Carmed Pharmaceuticals. “From the beginning, our objective has been to develop scientifically structured formulations guided by mechanism-based research and rigorous quality control. We combine nature’s bioactive potential with disciplined pharmaceutical methodology.”

All Carmed products are manufactured in facilities operating in accordance with Good Manufacturing Practice (GMP) principles and applicable regulatory standards, with an emphasis on safety, consistency, and long-term quality assurance.

Product Portfolio Entering the U.S.

Carmed Pharmaceuticals will introduce several of its flagship formulations to the U.S. market:

• Vacrol® Kids Spray – A carvacrol-based spray formulated to support upper respiratory wellness and microbial balance for children ages 4–11.

• S-Mix® – A synergy-driven formulation designed to support immune function and healthy cellular activity

• Omevaq-3® – A targeted formulation developed to support cellular energy metabolism and cognitive wellness.

Vacrol® Kids Spray and S-Mix® are gluten-free, non-GMO, sugar-free, preservative-free, and halal-certified.

“Our formulations are designed around rational synergy,” Can added. “Rather than relying on single ingredients, we develop standardized combinations selected to interact across multiple biological pathways in a consistent and reproducible manner.”

Scientific Collaboration and Long-Term Positioning

Carmed maintains academic collaborations and supports peer-reviewed research exploring bioactive mechanisms and formulation science. The company emphasizes that its research reflects scientific inquiry into botanical bioactivity and standardization practices and is not presented as evidence that its consumer products diagnose, treat, cure, or prevent any disease.

As it enters the United States, Carmed states its strategy is focused on regulatory alignment, long-term credibility, and preventive wellness positioning.

Distribution timelines and retail availability will be announced in the coming months.

About Carmed Pharmaceuticals

Carmed Pharmaceuticals is a research-driven company specializing in standardized, mechanism-based botanical formulations rooted in Anatolia’s rich botanical heritage. Integrating traditional plant knowledge with modern pharmaceutical technology, Carmed focuses on analytical validation, quality control, and reproducible formulation design.

Officially established in 2019 following years of focused research and development, the company operates with nearly 15 years of industry experience. All products are manufactured in accordance with Good Manufacturing Practice (GMP) principles and relevant regulatory standards, emphasizing safe production, environmental awareness, and continuous quality improvement.

Carmed develops standardized formulations designed to support preventive wellness, immune resilience, and cellular health through science-informed, quality-controlled processes.

Visit Carmed Pharmaceuticals website and visit them on Instagram.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.